The Bree Collaborative has approved its draft opioid prescribing metrics for dissemination for public comment. Read the draft metrics here. WSHA and the Washington State Medical Association’s Joint Opioid Taskforce has reviewed earlier versions of the Bree prescribing metrics and was supportive of their precision and direction. Our taskforce will re-review the metrics as they have undergone changes and provide formal comments to the collaborative. The collaborative is soliciting provider feedback on the measures through a survey.
We appreciate the collaborative’s leadership and work on these metrics, which will help address Washington’s opioid crisis. You can see the list of included and excluded opioids, and then take the survey to provide feedback. The survey, which will take 10-15 minutes to complete, must be completed by 5 p.m. June 23. The metrics are meant to put into practice previous guidelines and be used for quality improvement metrics. Final metrics will be submitted to the Washington State Health Care Authority.
Specifically, these prescribing metrics are meant to put into practice the 2015 guidelines from the Washington State Agency Medical Directors Group and the 2016 guidelines from the Centers for Disease Control and Prevention to be used for quality improvement internally by hospitals, clinics and health plans. They are also to show the state.
For more information or to give additional feedback, please contact Ginny Weir, Program Director of the Bree Collaborative, at GWeir@qualityhealth.org or (206) 204-7377, or visit www.breecollaborative.org. (Ian Corbridge)
